# AMLODIPINE AND OLMESARTAN MEDOXOMIL
> **ANDA207807** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2017-07-05
## Drug
- **FDA Application Number:** ANDA207807
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMLODIPINE AND OLMESARTAN MEDOXOMIL
- **Generic name:** AMLODIPINE AND OLMESARTAN MEDOXOMIL
- **Active ingredients:** AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** GLENMARK PHARMS LTD
- **Manufacturer:** Glenmark Pharmaceuticals Inc., USA
- **First approval:** 2017-07-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207807)
---
*AI Analytics · CC0 1.0*